Oral Breast Cancer Therapy Interventions in an Integrated Health System Specialty Pharmacy
We are proud to support the groundbreaking work of our specialty pharmacy solution, Lumicera Health Services. In alignment with our commitment to improving patient outcomes, a dedicated team of Lumicera pharmacists have authored a new white paper exploring the impact of pharmacist-led interventions in oral breast cancer therapy.
This multiyear study provides compelling statistical and clinical evidence of how pharmacist engagement influences the patient journey, from intervention acceptance rates to measurable improvements in outcomes. It’s a powerful example of how data-driven care and compassionate expertise can elevate the standard of specialty pharmacy.
We invite you to read the white paper and learn more about how Lumicera is driving innovation in oncological care.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Navigating with a trusted partner
Now Available: 9th Annual Drug Trend Report
Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.
Related blogs
Navigating Healthcare and Improving Outcomes
Oral Breast Cancer Therapy Interventions in an Integrated Health System Specialty Pharmacy
A dedicated team of Lumicera pharmacists have authored a new white paper exploring the impact of pharmacist-led interventions in oral breast cancer therapy….
